Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Net Margin (2016 - 2025)

Historic Net Margin for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to 0.2%.

  • AtriCure's Net Margin rose 65800.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.55%, marking a year-over-year increase of 31400.0%. This contributed to the annual value of 9.61% for FY2024, which is 19800.0% down from last year.
  • As of Q3 2025, AtriCure's Net Margin stood at 0.2%, which was up 65800.0% from 4.55% recorded in Q2 2025.
  • Over the past 5 years, AtriCure's Net Margin peaked at 137.82% during Q3 2021, and registered a low of 28.54% during Q1 2021.
  • Its 5-year average for Net Margin is 3.61%, with a median of 9.19% in 2023.
  • As far as peak fluctuations go, AtriCure's Net Margin surged by 1468600bps in 2021, and later crashed by -1525600bps in 2022.
  • Quarter analysis of 5 years shows AtriCure's Net Margin stood at 18.77% in 2021, then soared by 75bps to 4.74% in 2022, then crashed by -94bps to 9.19% in 2023, then plummeted by -36bps to 12.53% in 2024, then surged by 98bps to 0.2% in 2025.
  • Its Net Margin stands at 0.2% for Q3 2025, versus 4.55% for Q2 2025 and 5.46% for Q1 2025.